FBLG (FibroBiologics) Margin of Safety % (DCF FCF Based): N/A (As of Jun. 26, 2026)


FBLG FibroBiologics Inc FBLG
13 GF Score
Price $0.80
! 3 Warning Signs
View Full Analysis

What is FibroBiologics Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

FibroBiologics's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

FBLG vs BGMS, AIM, APVO: Margin of Safety % (DCF FCF Based) Comparison

For the Biotechnology subindustry, FibroBiologics's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

FibroBiologics Margin of Safety % (DCF FCF Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, FibroBiologics's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where FibroBiologics's Margin of Safety % (DCF FCF Based) falls into.


FBLG
13GF Score
FibroBiologics Inc FBLG
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

FibroBiologics Business Description

Address 455 East Medical Center Boulevard, Suite 300, Houston, TX, USA, 77598
FibroBiologics Inc a clinical-stage biotechnology company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including wound healing, multiple sclerosis, or MS, degenerative disc disease, psoriasis, certain cancers, and potential human longevity applications including thymic involution reversal using a thymic organoid. Its product candidates are CYWC628, CYPS317, CYMS101 and CybroCell.
13GF Score

Get the complete analysis for FBLG

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.80
Price